Effects of Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease: a Randomized Clinical Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Copd
- Sponsor
- Cardenal Herrera University
- Enrollment
- 30
- Primary Endpoint
- Quality of life measured with the Chronic Obstructive Pulmonary Disease Assessment Test: Score
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
The main objective of this study is to assess the effects of a myofascial release protocol in patients with chronic obstructive pulmonary disease (COPD).
Detailed Description
So far, there are no previous studies that analyze the effects of a myofascial relaxation protocol applied to the diaphragm within the respiratory rehabilitation treatment in patients with chronic obstructive pulmonary disease. Aim: The main objective of this study is to assess the effects of a 3 weeks myofascial release protocol applied to the diaphragm on respiratory parameters in patients with chronic obstructive pulmonary disease. Design: Randomized clinical trial
Investigators
ARGUISUELAS MARTINEZ MARÍA DOLORES
Head of Physiotherapy
Cardenal Herrera University
Eligibility Criteria
Inclusion Criteria
- •Forced expiratory volume in the first second (FEV1) \< 80%;
- •FEV1/Forced vital capacity (FVC) \< 70%;
- •Maximal inspiratory pressure (MIP) \< 70%.
Exclusion Criteria
- •Recent (6 months) spine or abdominal surgery;
- •Allergic status of any kind;
- •systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine diseases including diabetes, metabolic, and neoplastic syndromes);
- •neuromuscular or neurological injuries;
- •previous myofascial release treatment.
Outcomes
Primary Outcomes
Quality of life measured with the Chronic Obstructive Pulmonary Disease Assessment Test: Score
Time Frame: 3 weeks
Score (0-40) higher scores mean a worse outcome.
Secondary Outcomes
- 6 Minutes Walking Test(3 weeks)